Amazerx Participates In ERSP Forum

New York, NY– May 19, 2008 – The Electronic Retailing Self-Regulation Program (ERSP) has determined that AmazeRx, Ltd., can support the general efficacy claims it makes for the AmazeRx meal replacement product at the company’s Website. However, ERSP  recommended the marketer modify or discontinue claims made at a third-party Website and in broadcast advertising. The marketer’s advertising was brought to ERSP’s attention by a consumer complaint.

Claims at issue in the ERSP  inquiry included:

  • “AmazeRx allows you to lose weight without having to exercise”
  • “With AmazeRx, you can lose up to a pound a day while drinking a fantastic meal.”
  • “Because it is in a liquid form, it is absorbed directly into the body, much quicker than pills”
  • ERSP  determined that the claims at issue were adequately qualified and supported at the marketer’s Website, www.amazerx.com.

However, ERSP  recommended that the marketer modify or discontinue certain advertising claims that appear on a third-party affiliate Website, www.offcialtvwebsite.com/amazerx, and in an infomercial for the product.

ERSP  determined that the third-party Website contains streaming video and several consumer testimonials that appear with select typicality disclosures. ERSP  found that the small “results may vary” disclosure that appear with the consumer testimonials are not conspicuous and are not included with consumer testimonials which appear later on in the video.

Further, advertising at the third-party site does not make it clear that AmazeRx is a meal replacement program, an omission that communicates an ambiguous message to consumers. ERSP  recommended the marketer clearly disclose that information.   In addition, the third-party site includes a prominent “Lose up to a pound a day” claim — a primary issue in this inquiry. The claim was accompanied by  the express statement that “best of all AmazeRx allows you to lose weight without having to exercise.” ERSP  determined that meaningful weight loss of “up to a pound a day” without exercise appears possible in only the most extraordinary circumstances and recommended that this claim be discontinued in the context of both the infomercial and the third-party Website

ERSP, in its decision, noted that while ERSP  understands “that AmazeRx does not own the www.offcialtvwebsite.com/amazerx Website, it does license the product to the owner of the site.”

ERSP recommended that the marketer “exercise the necessary degree of due diligence to assure that the licensee markets the AmazeRx product truthfully and accurately.”

ERSP found that the fact that AmazeRx is a meal replacement program would be reasonably understood by consumers viewing the infomercial.

The company, in its marketer’s statement, said it would revise its “advertising to address [ERSP’s] concerns. AmazeRX will also communicate ERSP’s concerns to the owner” of the third-party Website.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

Direct Selling Self-Regulatory Council Recommends Lemongrass Discontinue Certain Earnings and Health-Related Product Claims

McLean, VA – May 6, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Lemongrass Spa Products modify or discontinue certain earnings and health-related product performance claims. 

Read the Decision Summary
Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary